Features of postoperative therapy in patients with type ІІ diabetes

Author:

Abstract

Type 2 diabetes mellitus (DM) is one of the most common diseases in the world. According to data of the International Diabetes Federation, there are more than 425 million people suffering from this disease in the world. The course of type II DM is accompanied by a progressive lesion of the macrovasculature, which is associated with an increase in the risk of developing atherosclerosis in this category of patients by 4-5 times in comparison with patients without diabetes. This in turn leads to some complications such as blindness, strokes, vascular damage of the limbs and chronic renal failure (CRF), which is often the leading cause of death. The occurrence of any inflammatory process against the background of diabetes is a significantly aggravating factor for the patient, as the body’s reserves are reduced, especially in the presence of CRF. The need for urgent surgical intervention in a patient with an inflammatory process against the background of diabetes is another stress factor. In addition, patients with DM are constantly taking hypoglycemic drugs, the effect of which in a stressful situation is not always predictable for the patient and therefore these drugs should be canceled. However, if the patient has CRF and long-term administration of drugs, their effect does not immediately stop. The combination of all the above points puts the patient with DM at a high risk group for the development of serious complications requiring intensive care (IT). Such complications in the early postoperative period may be lactic acidosis, persistent hypoglycemia, electrolyte disorders, cerebral edema. In the clinical case the pathogenesis of the development of these conditions and IT methods are described. Conclusions have been drawn regarding the need for close attention of anesthetists and intensive care physicians during perioperative therapy in patients with DM, complicated CRF, and which are receiving metformin.

Publisher

V. N. Karazin Kharkiv National University

Reference6 articles.

1. Order of the Ministry of Health of December 21, 2012 № 1118 “TYPE 2 DIABETES MELLITUS. Adapted, proven evidence-based guidance. https://dec.gov.ua/wp-content/uploads/2019/11/2012_1118akn.pdf

2. Demidova, Yu., Gorohova, T.V. (2009). Mechanism of Action and Clinical Use of Metformin (siofor®): Review of Literature. Farmateka, 17, 10-15. https://pharmateca.ru/en/archive/article/7645

3. Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B. and Birnbaum, M. J. (2013). Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP. Nature, 494, 256–260. DOI: 10.1038/nature11808

4. Severin, E. S. (2004). Biologicheskaya. Khimiya. Moskva: Hэotar-plius. 779с. http://biochem.vsmu.edu.ua/biochem_common_u/severin_biologicheskaya_khimiya.pdf

5. Pratley, R. E., Gilbert, M. (2015). Clinical management of elderly patients with type 2 diabetes mellitus. Postgrad Med, 1, 133–43. DOI: 10.3810/pgm.2012.01.2526

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3